Business Wednesday, Apr 24

PRINCETON, N.J. & NEW YORK–(BUSINESS WIRE)–Apr 23, 2024–Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift Plus TM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a complex mental…

Finance

Latest News

View More
© 2024 The Business Times. All Rights Reserved.